Literature DB >> 16355136

Top-down versus step-up approaches to chronic inflammatory bowel disease: presumed innocent or presumed guilty.

Stephen B Hanauer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16355136     DOI: 10.1038/ncpgasthep0318

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN: 1743-4378


× No keyword cloud information.
  9 in total

Review 1.  Future therapy for inflammatory bowel disease: should we rethink what we mean by "top down"?

Authors:  Michael J G Farthing
Journal:  Curr Gastroenterol Rep       Date:  2007-10

2.  Risk factors associated with postoperative recurrence and repeat surgery in Japanese patients with Crohn's disease.

Authors:  Jun Kusaka; Hisashi Shiga; Masatake Kuroha; Tomoya Kimura; Yoichi Kakuta; Katsuya Endo; Yoshitaka Kinouchi; Tooru Shimosegawa
Journal:  Int J Colorectal Dis       Date:  2017-07-22       Impact factor: 2.571

3.  Step-Up Versus Top-Down Therapy in the Treatment of Crohn's Disease.

Authors:  Daan W Hommes
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-08

Review 4.  Impact of medical therapies on inflammatory bowel disease complication rate.

Authors:  Catherine Reenaers; Jacques Belaiche; Edouard Louis
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

5.  Utilization trends of anti-TNF agents and health outcomes in adults and children with inflammatory bowel diseases: a single-center experience.

Authors:  K T Park; Aaron Sin; May Wu; Dorsey Bass; Jay Bhattacharya
Journal:  Inflamm Bowel Dis       Date:  2014-07       Impact factor: 5.325

6.  An evidence-based review of natalizumab therapy in the management of Crohn's disease.

Authors:  Raja Gr Edula; Michael F Picco
Journal:  Ther Clin Risk Manag       Date:  2009       Impact factor: 2.423

7.  Resection of a methicillin-resistant Staphylococcus aureus liver abscess in a patient with Crohn's disease under infliximab treatment: a case report.

Authors:  Junichi Togashi; Yasuhiko Sugawara; Nobuhisa Akamatsu; Taku Aoki; Masayoshi Ijichi; Mami Tanabe; Koji Kusaka; Masayuki Shibazaki; Tokuma Tadami; Minako Sakou; Masakazu Takazoe; Yasutsugu Bandai; Norihiro Kokudo
Journal:  J Med Case Rep       Date:  2013-02-01

Review 8.  A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease.

Authors:  Nadia Pillai; Mark Dusheiko; Bernard Burnand; Valérie Pittet
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

Review 9.  Is top-down therapy a more effective alternative to conventional step-up therapy for Crohn's disease?

Authors:  Jonathan Jenkin Tsui; Hien Q Huynh
Journal:  Ann Gastroenterol       Date:  2018-03-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.